1-(4'-Methoxy-biphenyl-4-yl)-ethanone, 95.0%, 200mg

1,2,3-Benzenetricarboxylic acid, 99.00%, 1g

2-Chloro-4-fluoronicotinonitrile, 95.0%, 10g

p-Maleimidophenylisocyanate, 95.0%, 5mg

3-Hydroxypyridine N-Oxide>96.0%(GC)(T)5g

GC capillary column ROTI®Cap-624, 30 m, 0.32 mm, 1.80 µm, 1 Piece(s)

2-Bromo-6-chlorothieno[2,3-b]pyridine, 95.0%, 500mg

3-CHLORO-4-NITRO-1H-INDOLE, 95.0%, 1g

butyl[(2,6-dichlorophenyl)methyl]amine, 95.0%, 10g

2-(2'-Di-tert-butylphosphine)biphenylpalladium(II) acetate, 97%, 5g

5-Amino-2-(4-aminophenyl)benzimidazole>98.0%(HPLC)1g

8-Hydroxy-7-iodoquinoline-5-sulfonic acid, 95.0%, 25g

Ethyl 2-Butynoate>98.0%(GC)5mL